Neuron23: Valuation, Funding & Investors
343 Oyster Point Blvd Suite 120 South San Francisco, California 94080, UShttps://neuron23.com/Precision Medicine
Neuron23 Inc. is a clinical-stage biotechnology company developing precision medicines for genetically defined neurological and immunological diseases. The company combines human genetics, drug discovery and biomarker platforms with machine learning and artificial intelligence to advance therapeutics for neurodegenerative, neuroinflammatory, and systemic autoimmune and inflammatory disorders.
Leadership & Board
- Current Number of Employees
- 28
- Current LinkedIn Followers
- 6,772
Latest Estimated Valuation
- Total Amount Raised
- $97M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $97M
- Latest Funding Round
- Series D
Employee Trend
Neuron23 had 28 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
28Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Neuron23 had 6,772 followers as of November 2, 2026. The number of followers increased by 15 (0.22%) week-over-week.
6,772Latest Followers Count
15(0.22%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jul 24, 2025 | Series D | $96.50M | ― |
Similar Companies
A snapshot of private companies similar to Neuron23, helping you discover and navigate related company profiles.
Related News and Analysis
